MedPath

Sapropterin Dihydrochloride

for oral solution. Initial U.S. Approval: 2007

Approved
Approval ID

9a8d9361-d600-4d11-33c1-e0ecd56aaf2d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 8, 2020

Manufacturers
FDA

Dr. Reddys Laboratories Inc

DUNS: 802315887

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sapropterin Dihydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43598-477
Application NumberANDA209452
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sapropterin Dihydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateDecember 8, 2020
FDA Product Classification

INGREDIENTS (5)

Sapropterin DihydrochlorideActive
Quantity: 100 mg in 1 1
Code: RG277LF5B3
Classification: ACTIB
SucraloseInactive
Code: 96K6UQ3ZD4
Classification: IACT
Potassium CitrateInactive
Code: EE90ONI6FF
Classification: IACT
Ascorbic AcidInactive
Code: PQ6CK8PD0R
Classification: IACT
MannitolInactive
Code: 3OWL53L36A
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sapropterin Dihydrochloride - FDA Drug Approval Details